Montana InciWeb: Lolo Peak Fire
Mylan
Agrees to Pay $465 Million to Resolve False Claims Act Liability for
Underpaying EpiPen Rebates
“Pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. have agreed to pay $465 million to resolve claims that they violated the False Claims Act by knowingly misclassifying EpiPen as a generic drug to avoid paying rebates owed primarily to Medicaid, the Justice Department announced today. Mylan Inc. and Mylan Specialty L.P. are both wholly owned subsidiaries of Mylan N.V., which is headquartered in Canonsburg, Pennsylvania.”
“Pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. have agreed to pay $465 million to resolve claims that they violated the False Claims Act by knowingly misclassifying EpiPen as a generic drug to avoid paying rebates owed primarily to Medicaid, the Justice Department announced today. Mylan Inc. and Mylan Specialty L.P. are both wholly owned subsidiaries of Mylan N.V., which is headquartered in Canonsburg, Pennsylvania.”
“Sad to see the history and culture of our great country
being ripped apart with the removal of our beautiful statues and monuments.
You..... ..can't change history, but you can learn from it. Robert E Lee,
Stonewall Jackson - who's next, Washington, Jefferson? So foolish! Also... ...the
beauty that is being taken out of our cities, towns and parks will be greatly
missed and never able to be comparably replaced!”
No comments:
Post a Comment